drugset / Trial / NCT03268343

A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine

NCT03268343

Phase 1 Completed 24 enrolled Achieve Life Sciences
RandomizedCrossoverOpen-labelTreatment

Summary

This will be an open-label, randomised, 2-period, single-dose crossover study to determine the comparative bioavailability of cytisine following single-dose administration in healthy male and female subjects under fed and fasted conditions. The study will be comprised of a pre-study screen, followed by 2 treatment periods (1 and 2) and a post-study follow-up.

Timeline

Start
2017-08-08
Primary completion
2017-08-26
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytisinicline Small molecule 3 mg

Indications

No indication recorded.